Biotech Acquisition Co Stock Book Value Per Share
| BIOTDelisted Stock | USD 10.15 0.00 0.00% |
Biotech Acquisition Co fundamentals help investors to digest information that contributes to Biotech Acquisition's financial success or failures. It also enables traders to predict the movement of Biotech Stock. The fundamental analysis module provides a way to measure Biotech Acquisition's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotech Acquisition stock.
Biotech |
Biotech Acquisition Co Company Book Value Per Share Analysis
Biotech Acquisition's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Biotech Acquisition Book Value Per Share | (0.46) X |
Most of Biotech Acquisition's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Acquisition Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Biotech Acquisition Co is about -0.456 times. This is 100.55% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The book value per share for all United States stocks is 100.02% higher than that of the company.
Biotech Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotech Acquisition's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biotech Acquisition could also be used in its relative valuation, which is a method of valuing Biotech Acquisition by comparing valuation metrics of similar companies.Biotech Acquisition is currently under evaluation in book value per share category among its peers.
Biotech Fundamentals
| Return On Asset | -0.0085 | |||
| Current Valuation | 290.09 M | |||
| Shares Outstanding | 23 M | |||
| Shares Owned By Institutions | 100.00 % | |||
| Number Of Shares Shorted | 9.3 K | |||
| Price To Earning | 29.21 X | |||
| Price To Book | 1.33 X | |||
| EBITDA | (6.86 M) | |||
| Net Income | (6.86 M) | |||
| Cash And Equivalents | 1.7 K | |||
| Total Debt | 153.35 K | |||
| Debt To Equity | 3.48 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.46) X | |||
| Cash Flow From Operations | (1.47 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | 0.26 X | |||
| Market Capitalization | 291.81 M | |||
| Total Asset | 230 | |||
| Net Asset | 230 |
About Biotech Acquisition Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotech Acquisition Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotech Acquisition using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotech Acquisition Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Biotech Stock
If you are still planning to invest in Biotech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotech Acquisition's history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |